Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
apnews.com
politics
2022-06-01 20:17:57

BOSTON, June 01, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and other public health threats for civilian, government andÂ military use, today announced that on May 31, 2022, the Company granted stock options and restricted stock units to twelve new employees of the Company. These awards were granted pursuant to the Paratek Pharmaceuticals, Inc.
